Trial Profile
A phase I trial of MER 3001 in type 1 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Apr 2016
Price :
$35
*
At a glance
- Drugs MER 3001 (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- 25 Apr 2016 New trial record